Literature DB >> 2117918

Differential modification of cyclo-oxygenase and peroxidase activities of prostaglandin endoperoxidase synthase by proteolytic digestion and hydroperoxides.

A Raz1, P Needleman.   

Abstract

Prostaglandin endoperoxide synthase (PES, EC 1.14.99.1) catalyse the conversion of arachidonic acid into prostaglandin H2. The enzyme is a 140 kDa homodimer which contains both a cyclo-oxygenase activity (converting arachidonate into prostaglandin G2) and peroxidase activity (reducing prostaglandin G2 to H2). PES undergoes rapid self-inactivation during oxygenation of arachidonate to prostaglandin H2 in vitro. The previously reported cDNA-derived amino acid sequence indicates numerous sites for trypsin or thrombin cleavage. Most of these sites must be inaccessible, since these enzymes cleave only at Arg253. The enzyme appears to be a self-adherent and highly folded molecule, since after cleavage it retains its functional assembly and its homodimer size of 140 kDa, as well as its overall enzymic activity. Only under denaturing conditions (e.g. SDS/PAGE) can the proteolytic peptides be demonstrated: a 38 kDa C-terminal fragment containing the aspirin-derived-acetyl-binding ability, and a 33 kDa N-terminal fragment. In the present studies we investigated whether the two enzymic activities of PES can be differentially manipulated by proteolytic cleavage or by substrate (arachidonate) self-inactivation. The results indicated that, during arachidonate oxygenation by PES, the cyclooxygenase activity is selectively inactivated, whereas the peroxidase activity is essentially retained. By contrast, thrombin or trypsin cleavage of pure PES or microsomal PES (to yield the 38 and 33 kDa peptide fragments) inactivated the peroxidase, but not the cyclo-oxygenase. Taken together, these results suggest the presence of separate cyclo-oxygenase and peroxidase structural domains on the enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117918      PMCID: PMC1131629          DOI: 10.1042/bj2690603

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Prostaglandin H synthase and hydroperoxides: peroxidase reaction and inactivation kinetics.

Authors:  R J Kulmacz
Journal:  Arch Biochem Biophys       Date:  1986-09       Impact factor: 4.013

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Prostaglandin G2 levels during reaction of prostaglandin H synthase with arachidonic acid.

Authors:  R J Kulmacz
Journal:  Prostaglandins       Date:  1987-08

4.  Topography of prostaglandin H synthase. Antiinflammatory agents and the protease-sensitive arginine 253 region.

Authors:  R J Kulmacz
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

5.  Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities.

Authors:  C M Markey; A Alward; P E Weller; L J Marnett
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

6.  Iothalamate stimulates hydroperoxide formation by soybean lipoxygenase.

Authors:  A R Morrison; W Brown; N Tauk
Journal:  Prostaglandins       Date:  1984-05

7.  Structural characteristics of prostaglandin synthetase from sheep vesicular gland.

Authors:  G J Roth; C J Siok; J Ozols
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

8.  Peroxidative oxidation of bilirubin during prostaglandin biosynthesis.

Authors:  G A Reed; J M Lasker; T E Eling; K Sivarajah
Journal:  Prostaglandins       Date:  1985-07

9.  Purification of prostaglandin H synthetase and a fluorometric assay for its activity.

Authors:  A T Mevkh; G F Sud'ina; N B Golub; S D Varfolomeev
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency.

Authors:  J B Lefkowith; V Flippo; H Sprecher; P Needleman
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

View more
  2 in total

1.  Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant.

Authors:  Bruce P Burnett; Alessandra Bitto; Domenica Altavilla; Francesco Squadrito; Robert M Levy; Lakshmi Pillai
Journal:  Mediators Inflamm       Date:  2011-06-19       Impact factor: 4.711

2.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.